CEFEPIME

CEFEPIME was reported 16330 times

CEFEPIME is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MENINGITIS CANDIDA 9 0.1286
1 BURKHOLDERIA TEST POSITIVE 15 0.1210
2 TRICHOSPORON INFECTION 29 0.0716
3 AEROMONAS INFECTION 13 0.0688
4 HEPATOSPLENIC CANDIDIASIS 10 0.0680
5 CUTANEOUS MUCORMYCOSIS 12 0.0652
6 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 26 0.0640
7 HYPEROXALURIA 9 0.0523
8 PHRENIC NERVE PARALYSIS 10 0.0457
9 URAEMIC ENCEPHALOPATHY 14 0.0447
10 SEPTIC EMBOLUS 37 0.0445
11 HUMAN EHRLICHIOSIS 9 0.0431
12 GEOTRICHUM INFECTION 9 0.0427
13 CNS VENTRICULITIS 13 0.0399
14 DISSEMINATED MUCORMYCOSIS 15 0.0381
15 NAIL BED INFLAMMATION 12 0.0376
16 FUNGAEMIA 58 0.0368
17 CEREBRAL ASPERGILLOSIS 22 0.0358
18 NEPHRITIS ALLERGIC 14 0.0353
19 EYE INFECTION FUNGAL 13 0.0336
20 ENTEROCOCCAL BACTERAEMIA 35 0.0330
21 VANCOMYCIN INFUSION REACTION 12 0.0318
22 PNEUMONIA NECROTISING 20 0.0309
23 FUSARIUM INFECTION 20 0.0286
24 UREAPLASMA INFECTION 11 0.0270
25 CORYNEBACTERIUM INFECTION 14 0.0262
26 METHAEMOGLOBINAEMIA 60 0.0259
27 STENOTROPHOMONAS INFECTION 35 0.0258
28 CRYSTALLURIA 14 0.0257
29 CYTOMEGALOVIRUS ENTEROCOLITIS 19 0.0247
30 ENTEROCOCCUS TEST POSITIVE 15 0.0231
31 DYSBIOSIS 19 0.0231
32 BLASTOMYCOSIS 11 0.0226
33 DISSEMINATED CRYPTOCOCCOSIS 17 0.0225
34 ECTHYMA 9 0.0224
35 MUCORMYCOSIS 58 0.0223
36 SPUTUM CULTURE POSITIVE 18 0.0222
37 DIFFERENTIATION SYNDROME 16 0.0218
38 URINARY TRACT INFECTION PSEUDOMONAL 13 0.0216
39 NEUTROPENIC COLITIS 44 0.0213
40 PULMONARY MUCORMYCOSIS 11 0.0208
41 ENCEPHALOPATHY 510 0.0207
42 MEDIASTINITIS 12 0.0207
43 ENTEROCOCCAL INFECTION 100 0.0207
44 GLOMERULOSCLEROSIS 13 0.0206
45 BACILLUS INFECTION 13 0.0206
46 CYTOKINE STORM 14 0.0204
47 NECROTISING RETINITIS 13 0.0203
48 ENGRAFTMENT SYNDROME 12 0.0203
49 CAECITIS 9 0.0200
50 PSEUDOMONAL BACTERAEMIA 17 0.0199
51 MALACOPLAKIA 9 0.0197
52 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 152 0.0195
53 ENTEROBACTER INFECTION 32 0.0190
54 NASAL MUCOSAL DISORDER 11 0.0189
55 PROCALCITONIN INCREASED 22 0.0187
56 ENTEROCOCCAL SEPSIS 15 0.0185
57 ACINETOBACTER INFECTION 20 0.0183
58 LINEAR IGA DISEASE 30 0.0180
59 RETINAL ISCHAEMIA 11 0.0180
60 CHOLESTATIC LIVER INJURY 39 0.0175
61 DIFFUSE ALVEOLAR DAMAGE 20 0.0174
62 ABDOMINAL COMPARTMENT SYNDROME 11 0.0173
63 PSEUDOMONAS TEST POSITIVE 14 0.0171
64 SJS-TEN OVERLAP 12 0.0171
65 MITOCHONDRIAL TOXICITY 14 0.0171
66 RED MAN SYNDROME 15 0.0170
67 TOXIC ENCEPHALOPATHY 86 0.0170
68 DISSEMINATED ASPERGILLOSIS 8 0.0169
69 BOTULISM 14 0.0169
70 KLEBSIELLA TEST POSITIVE 11 0.0169
71 SYSTEMIC CANDIDA 42 0.0167
72 NEUROTOXICITY 277 0.0158
73 SYSTEMIC MYCOSIS 18 0.0154
74 PSEUDOMONAL SEPSIS 27 0.0154
75 KLEBSIELLA INFECTION 77 0.0152
76 CLOSTRIDIUM DIFFICILE COLITIS 160 0.0151
77 BRAIN HERNIATION 45 0.0151
78 DIAPHRAGMATIC PARALYSIS 9 0.0150
79 PNEUMONIA PSEUDOMONAL 23 0.0150
80 KLEBSIELLA BACTERAEMIA 14 0.0147
81 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 87 0.0147
82 METABOLIC ENCEPHALOPATHY 44 0.0146
83 PSEUDOMONAS INFECTION 124 0.0144
84 RENAL TUBULAR NECROSIS 141 0.0144
85 BLOOD CULTURE POSITIVE 43 0.0143
86 TRACHEOBRONCHITIS 11 0.0143
87 SUBCUTANEOUS EMPHYSEMA 14 0.0143
88 MYCOBACTERIUM ABSCESSUS INFECTION 10 0.0140
89 MENINGITIS BACTERIAL 20 0.0140
90 EOSINOPHILIC PNEUMONIA ACUTE 12 0.0139
91 CYTOKINE RELEASE SYNDROME 277 0.0138
92 STREPTOCOCCAL BACTERAEMIA 15 0.0138
93 SINUSITIS FUNGAL 11 0.0137
94 RESPIRATORY ALKALOSIS 22 0.0135
95 SERRATIA INFECTION 10 0.0134
96 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 11 0.0134
97 CANDIDA SEPSIS 12 0.0134
98 STATUS EPILEPTICUS 147 0.0130
99 STRONGYLOIDIASIS 21 0.0130
100 MYOCLONUS 154 0.0129
101 PATHOGEN RESISTANCE 117 0.0128
102 CLOSTRIDIUM TEST POSITIVE 28 0.0127
103 STREPTOCOCCAL SEPSIS 15 0.0126
104 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 325 0.0126
105 RASH MORBILLIFORM 35 0.0126
106 PNEUMOCYSTIS JIROVECII INFECTION 15 0.0126
107 PSEUDOMEMBRANOUS COLITIS 28 0.0125
108 IMMUNE THROMBOCYTOPENIA 57 0.0124
109 SLOW RESPONSE TO STIMULI 16 0.0123
110 CULTURE URINE POSITIVE 17 0.0121
111 MIXED LIVER INJURY 36 0.0120
112 ASPERGILLUS INFECTION 78 0.0119
113 BRONCHOPULMONARY ASPERGILLOSIS 92 0.0119
114 CATHETER RELATED INFECTION 12 0.0118
115 INTRACRANIAL MASS 11 0.0116
116 CLOSTRIDIAL INFECTION 39 0.0115
117 ESCHERICHIA BACTERAEMIA 27 0.0115
118 BACTERAEMIA 136 0.0114
119 PNEUMONIA KLEBSIELLA 21 0.0114
120 STAPHYLOCOCCUS TEST POSITIVE 24 0.0114
121 MULTIPLE ORGAN DYSFUNCTION SYNDROME 321 0.0113
122 CONTINUOUS HAEMODIAFILTRATION 11 0.0112
123 PNEUMONIA FUNGAL 44 0.0111
124 VENOOCCLUSIVE LIVER DISEASE 55 0.0111
125 PNEUMOMEDIASTINUM 20 0.0111
126 ELECTROCARDIOGRAM T WAVE ABNORMAL 17 0.0109
127 SEPTIC SHOCK 472 0.0108
128 FUNGAL SEPSIS 9 0.0108
129 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 10 0.0108
130 ACUTE RESPIRATORY DISTRESS SYNDROME 190 0.0107
131 URINARY TRACT INFECTION ENTEROCOCCAL 10 0.0107
132 HISTOPLASMOSIS DISSEMINATED 17 0.0107
133 HYPERTENSIVE HEART DISEASE 20 0.0107
134 CEREBRAL ARTERY EMBOLISM 13 0.0107
135 HYPERCAPNIA 32 0.0106
136 NEPHROPATHY TOXIC 119 0.0106
137 LARGE INTESTINE INFECTION 13 0.0106
138 FEBRILE NEUTROPENIA 696 0.0105
139 EOSINOPHILIC PNEUMONIA 33 0.0105
140 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 77 0.0103
141 ISCHAEMIC HEPATITIS 14 0.0102
142 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 39 0.0102
143 NOCARDIOSIS 26 0.0102
144 DEVICE RELATED SEPSIS 20 0.0099
145 AUTOIMMUNE HAEMOLYTIC ANAEMIA 34 0.0099
146 CYTOMEGALOVIRUS VIRAEMIA 44 0.0099
147 INFECTIOUS PLEURAL EFFUSION 15 0.0098
148 PNEUMONIA CYTOMEGALOVIRAL 19 0.0098
149 MENTAL STATUS CHANGES 269 0.0097
150 PNEUMONIA STAPHYLOCOCCAL 19 0.0096
151 STAPHYLOCOCCAL BACTERAEMIA 41 0.0094
152 HYPORESPONSIVE TO STIMULI 11 0.0094
153 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 24 0.0093
154 LUNG CONSOLIDATION 26 0.0093
155 ACUTE RESPIRATORY FAILURE 178 0.0092
156 EPIDERMAL NECROSIS 9 0.0092
157 HAEMOPHILUS INFECTION 9 0.0092
158 HENOCH-SCHONLEIN PURPURA 20 0.0091
159 BRAIN ABSCESS 23 0.0091
160 HAEMODYNAMIC INSTABILITY 69 0.0090
161 VASCULAR DEVICE INFECTION 41 0.0090
162 PERIRECTAL ABSCESS 10 0.0090
163 VANISHING BILE DUCT SYNDROME 10 0.0090
164 CYTOMEGALOVIRUS TEST POSITIVE 16 0.0090
165 TUBULOINTERSTITIAL NEPHRITIS 167 0.0089
166 PULSELESS ELECTRICAL ACTIVITY 37 0.0088
167 BLOOD FIBRINOGEN DECREASED 10 0.0088
168 MULTIPLE-DRUG RESISTANCE 27 0.0087
169 NEPHRITIS INTERSTITIAL 11 0.0087
170 PHARYNGEAL INFLAMMATION 10 0.0082
171 CAPILLARY LEAK SYNDROME 17 0.0082
172 NOSOCOMIAL INFECTION 18 0.0082
173 EOSINOPHILIA 141 0.0080
174 ORGANISING PNEUMONIA 39 0.0079
175 ACUTE KIDNEY INJURY 1185 0.0077
176 HAEMODIALYSIS 65 0.0077
177 ACIDOSIS 59 0.0077
178 BLAST CELL COUNT INCREASED 8 0.0076
179 HYPOXIA 267 0.0076
180 PRODUCT CONTAMINATION MICROBIAL 9 0.0075
181 CANDIDA INFECTION 127 0.0075
182 HEPARIN-INDUCED THROMBOCYTOPENIA 37 0.0075
183 RENAL TUBULAR INJURY 9 0.0074
184 NECROTISING FASCIITIS 26 0.0074
185 ARRHYTHMIA SUPRAVENTRICULAR 8 0.0073
186 LUNG INFILTRATION 64 0.0072
187 DRUG RESISTANCE 186 0.0072
188 RETROPERITONEAL HAEMATOMA 16 0.0072
189 VENOOCCLUSIVE DISEASE 18 0.0072
190 TOXIC EPIDERMAL NECROLYSIS 109 0.0072
191 TUMOUR LYSIS SYNDROME 63 0.0072
192 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 36 0.0071
193 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 10 0.0071
194 HYPERPHOSPHATAEMIA 15 0.0070
195 CEREBRAL VENTRICLE DILATATION 8 0.0069
196 KIDNEY FIBROSIS 12 0.0069
197 HYPERSENSITIVITY VASCULITIS 18 0.0068
198 LEUKOCYTOSIS 124 0.0068
199 LIVER ABSCESS 22 0.0068
200 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 18 0.0068
201 ENTEROCOLITIS 39 0.0067
202 DISSEMINATED INTRAVASCULAR COAGULATION 95 0.0067
203 ELECTROENCEPHALOGRAM ABNORMAL 21 0.0066
204 APLASIA 13 0.0066
205 CHRONIC RESPIRATORY FAILURE 8 0.0066
206 HEPATOSPLENOMEGALY 17 0.0066
207 DISTRIBUTIVE SHOCK 15 0.0066
208 PNEUMONIA VIRAL 21 0.0066
209 ATELECTASIS 63 0.0065
210 HISTIOCYTOSIS HAEMATOPHAGIC 19 0.0064
211 MULTI-ORGAN FAILURE 110 0.0064
212 SPLENIC INFARCTION 11 0.0063
213 RESPIRATORY FAILURE 452 0.0062
214 DRUG LEVEL INCREASED 102 0.0062
215 CLOSTRIDIUM DIFFICILE INFECTION 134 0.0061
216 CRYPTOCOCCOSIS 10 0.0061
217 PULMONARY HAEMORRHAGE 48 0.0061
218 DRUG CLEARANCE DECREASED 8 0.0061
219 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 20 0.0060
220 ENDOCARDITIS 31 0.0060
221 MYCOBACTERIUM AVIUM COMPLEX INFECTION 16 0.0060
222 LOBAR PNEUMONIA 11 0.0059
223 ADENOVIRUS INFECTION 17 0.0059
224 RASH MACULO-PAPULAR 130 0.0058
225 HYPERNATRAEMIA 29 0.0058
226 CHOREA 10 0.0058
227 STREPTOCOCCAL INFECTION 32 0.0057
228 SHOCK 131 0.0057
229 HERPES SIMPLEX 37 0.0057
230 INHIBITORY DRUG INTERACTION 9 0.0057
231 CYTOMEGALOVIRUS COLITIS 13 0.0056
232 HYPOVOLAEMIC SHOCK 27 0.0056
233 CHOLESTASIS 108 0.0056
234 ACUTE MYELOID LEUKAEMIA RECURRENT 12 0.0056
235 URINARY TRACT INFECTION BACTERIAL 14 0.0055
236 BACTERIAL SEPSIS 18 0.0055
237 BRAIN DEATH 17 0.0055
238 CUTANEOUS VASCULITIS 20 0.0055
239 OLIGURIA 34 0.0055
240 HYPERTRANSAMINASAEMIA 38 0.0055
241 AGRANULOCYTOSIS 101 0.0054
242 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 15 0.0054
243 PANCYTOPENIA 300 0.0054
244 PNEUMONIA BACTERIAL 49 0.0053
245 SERUM FERRITIN INCREASED 28 0.0053
246 BLOOD PH DECREASED 9 0.0053
247 HYPERAMMONAEMIA 26 0.0052
248 ABSCESS LIMB 22 0.0052
249 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 12 0.0052
250 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 28 0.0051
251 PERIPHERAL ISCHAEMIA 21 0.0051
252 HYPERBILIRUBINAEMIA 53 0.0051
253 KYPHOSIS 9 0.0051
254 PLEURITIC PAIN 14 0.0051
255 HYPERVOLAEMIA 25 0.0051
256 DIPLEGIA 10 0.0050
257 SEPSIS 562 0.0050
258 EMPYEMA 10 0.0050
259 DRUG LEVEL ABOVE THERAPEUTIC 23 0.0050
260 AZOTAEMIA 20 0.0050
261 GRAFT VERSUS HOST DISEASE 36 0.0050
262 RESPIRATORY DISTRESS 138 0.0050
263 PNEUMOCYSTIS JIROVECII PNEUMONIA 50 0.0050
264 GASTROINTESTINAL ULCER 11 0.0050
265 IMMUNE THROMBOCYTOPENIC PURPURA 14 0.0049
266 STAPHYLOCOCCAL INFECTION 162 0.0049
267 ANURIA 42 0.0049
268 RENAL FAILURE ACUTE 205 0.0048
269 THROMBOTIC THROMBOCYTOPENIC PURPURA 17 0.0048
270 SKIN NECROSIS 25 0.0048
271 LUNG ABSCESS 10 0.0048
272 BRAIN OEDEMA 60 0.0047
273 MECHANICAL VENTILATION 9 0.0047
274 HYPERTHERMIA 36 0.0047
275 PURPURA 41 0.0046
276 HEPATIC LESION 20 0.0046
277 PERIODONTITIS 10 0.0046
278 APLASTIC ANAEMIA 24 0.0046
279 COVID-19 PNEUMONIA 54 0.0046
280 TACHYPNOEA 62 0.0046
281 PNEUMATOSIS INTESTINALIS 13 0.0046
282 CREATININE RENAL CLEARANCE DECREASED 18 0.0045
283 BK VIRUS INFECTION 15 0.0044
284 WOUND DEHISCENCE 15 0.0044
285 INTRAVENTRICULAR HAEMORRHAGE 11 0.0044
286 DERMATITIS BULLOUS 32 0.0044
287 THROMBOCYTOPENIA 493 0.0044
288 BLOOD UREA INCREASED 72 0.0043
289 ENDOTRACHEAL INTUBATION 12 0.0043
290 AORTIC ARTERIOSCLEROSIS 11 0.0043
291 OSTEOMYELITIS 77 0.0042
292 ACUTE LYMPHOCYTIC LEUKAEMIA 12 0.0042
293 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 9 0.0042
294 STEVENS-JOHNSON SYNDROME 94 0.0042
295 UNRESPONSIVE TO STIMULI 109 0.0042
296 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 21 0.0042
297 PULSE ABSENT 20 0.0042
298 MUCOSAL INFLAMMATION 110 0.0042
299 LACTIC ACIDOSIS 136 0.0042
300 LEFT VENTRICULAR DYSFUNCTION 28 0.0042
301 CEREBRAL HAEMATOMA 14 0.0042
302 METABOLIC ACIDOSIS 133 0.0042
303 DEVICE RELATED INFECTION 64 0.0042
304 ESCHERICHIA SEPSIS 12 0.0041
305 GRAFT VERSUS HOST DISEASE IN SKIN 9 0.0041
306 RESPIRATORY ACIDOSIS 16 0.0041
307 LARGE INTESTINAL ULCER 11 0.0040
308 STAPHYLOCOCCAL SEPSIS 20 0.0040
309 COLITIS ISCHAEMIC 27 0.0040
310 CYSTITIS HAEMORRHAGIC 16 0.0040
311 STRESS CARDIOMYOPATHY 23 0.0040
312 PANCREATITIS NECROTISING 9 0.0039
313 RENAL TUBULAR DISORDER 11 0.0039
314 HAEMOLYTIC ANAEMIA 35 0.0039
315 SMALL INTESTINAL OBSTRUCTION 48 0.0039
316 BLOOD CHLORIDE DECREASED 10 0.0039
317 DIALYSIS 55 0.0039
318 SINUS TACHYCARDIA 55 0.0039
319 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 212 0.0039
320 RHINOVIRUS INFECTION 15 0.0039
321 ACUTE MYELOID LEUKAEMIA 60 0.0038
322 HEPATIC CYTOLYSIS 49 0.0038
323 COAGULOPATHY 64 0.0038
324 INFLAMMATORY MARKER INCREASED 19 0.0038
325 DRUG-INDUCED LIVER INJURY 120 0.0038
326 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 10 0.0038
327 DILATATION VENTRICULAR 8 0.0038
328 LACUNAR INFARCTION 9 0.0038
329 HYPOVOLAEMIA 22 0.0038
330 HAEMOLYSIS 29 0.0038
331 HYPOTHERMIA 38 0.0037
332 DIABETES INSIPIDUS 9 0.0037
333 ORGAN FAILURE 15 0.0037
334 NEUTROPHILIA 21 0.0037
335 PROTHROMBIN TIME PROLONGED 22 0.0037
336 TRANSPLANT FAILURE 9 0.0037
337 DRUG ERUPTION 65 0.0037
338 SUBDURAL HAEMORRHAGE 10 0.0037
339 RETROPERITONEAL HAEMORRHAGE 9 0.0036
340 ESCHERICHIA INFECTION 30 0.0036
341 ATRIAL FLUTTER 29 0.0036
342 BLOOD LACTIC ACID INCREASED 19 0.0036
343 HYPOALBUMINAEMIA 28 0.0036
344 HEPATOCELLULAR INJURY 51 0.0036
345 PNEUMOTHORAX 57 0.0036
346 SEROTONIN SYNDROME 69 0.0036
347 BACTERIAL INFECTION 67 0.0036
348 BACTERIAL TEST POSITIVE 8 0.0036
349 NEUTROPENIA 486 0.0036
350 BLOOD CREATININE INCREASED 233 0.0036
351 ASPARTATE AMINOTRANSFERASE INCREASED 188 0.0035
352 COMPUTERISED TOMOGRAM ABNORMAL 8 0.0035
353 DISSEMINATED TUBERCULOSIS 9 0.0035
354 NEUTROPENIC SEPSIS 25 0.0035
355 CACHEXIA 18 0.0035
356 ACUTE GRAFT VERSUS HOST DISEASE 16 0.0035
357 CARDIAC DYSFUNCTION 13 0.0035
358 TOXIC SKIN ERUPTION 35 0.0035
359 ENCEPHALITIS 24 0.0035
360 FAILURE TO THRIVE 18 0.0035
361 HEPATIC NECROSIS 13 0.0034
362 RALES 20 0.0034
363 VENTRICULAR HYPOKINESIA 11 0.0034
364 LUNG OPACITY 9 0.0034
365 GENERALISED OEDEMA 42 0.0034
366 FIBRIN D DIMER INCREASED 12 0.0034
367 PLEURAL EFFUSION 205 0.0034
368 BLOOD BILIRUBIN INCREASED 91 0.0034
369 FLUID OVERLOAD 49 0.0034
370 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 32 0.0033
371 HYPOGAMMAGLOBULINAEMIA 22 0.0033
372 CARDIOPULMONARY FAILURE 13 0.0033
373 LEUKOPENIA 166 0.0033
374 URINE OUTPUT DECREASED 29 0.0033
375 LIVER INJURY 81 0.0033
376 NEUTROPHIL COUNT DECREASED 134 0.0033
377 TYPE IV HYPERSENSITIVITY REACTION 9 0.0033
378 FAECALOMA 18 0.0033
379 TRANSAMINASES INCREASED 73 0.0033
380 HYPERKALAEMIA 115 0.0033
381 BUNDLE BRANCH BLOCK RIGHT 15 0.0033
382 CHEST X-RAY ABNORMAL 10 0.0033
383 CEREBRAL ATROPHY 13 0.0033
384 CANDIDIASIS 13 0.0032
385 PNEUMONITIS 88 0.0032
386 PULMONARY ALVEOLAR HAEMORRHAGE 18 0.0032
387 DELIRIUM 111 0.0032
388 DERMATITIS EXFOLIATIVE 16 0.0032
389 CATHETER SITE INFECTION 12 0.0032
390 OESOPHAGEAL STENOSIS 9 0.0032
391 HYPERREFLEXIA 11 0.0032
392 BLOOD ALBUMIN DECREASED 25 0.0031
393 VENTRICULAR TACHYCARDIA 52 0.0031
394 HYDROCEPHALUS 17 0.0031
395 BRONCHIECTASIS 21 0.0031
396 APHASIA 94 0.0031
397 BONE MARROW FAILURE 63 0.0031
398 SHOCK HAEMORRHAGIC 25 0.0031
399 CARDIOGENIC SHOCK 44 0.0031
400 SUBARACHNOID HAEMORRHAGE 31 0.0030
401 PURULENT DISCHARGE 13 0.0030
402 EPSTEIN-BARR VIRUS INFECTION 19 0.0030
403 SUPRAVENTRICULAR TACHYCARDIA 29 0.0030
404 RASH PUSTULAR 22 0.0030
405 OESOPHAGITIS 33 0.0030
406 ABDOMINAL TENDERNESS 15 0.0030
407 ELECTROLYTE IMBALANCE 35 0.0030
408 OESOPHAGEAL CANDIDIASIS 12 0.0030
409 AREFLEXIA 8 0.0030
410 RIGHT VENTRICULAR FAILURE 21 0.0030
411 ALANINE AMINOTRANSFERASE INCREASED 183 0.0030
412 INTESTINAL PERFORATION 33 0.0029
413 CLONUS 8 0.0029
414 SUBCUTANEOUS ABSCESS 14 0.0029
415 HEPATIC FAILURE 88 0.0029
416 LYMPHOCYTE COUNT DECREASED 51 0.0029
417 SUSPECTED OFF LABEL USE 13 0.0029
418 NECROSIS 16 0.0029
419 TRANSPLANT REJECTION 23 0.0029
420 MALNUTRITION 32 0.0029
421 CYTOPENIA 35 0.0029
422 ODYNOPHAGIA 17 0.0028
423 ESCHERICHIA URINARY TRACT INFECTION 12 0.0028
424 HYPOTENSION 565 0.0028
425 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 14 0.0027
426 CARDIAC ARREST 227 0.0027
427 TACHYCARDIA 243 0.0027
428 PARONYCHIA 12 0.0027
429 HYPOKALAEMIA 126 0.0027
430 PEPTIC ULCER 9 0.0027
431 UROSEPSIS 25 0.0027
432 HYPOPHOSPHATAEMIA 20 0.0027
433 DECUBITUS ULCER 22 0.0027
434 NEPHRITIS 9 0.0027
435 HYPERURICAEMIA 11 0.0027
436 HYPERCALCAEMIA 33 0.0027
437 RENAL IMPAIRMENT 224 0.0027
438 PYREXIA 919 0.0027
439 B-CELL LYMPHOMA 9 0.0026
440 INTERNATIONAL NORMALISED RATIO INCREASED 75 0.0026
441 BRONCHOPNEUMONIA 9 0.0026
442 BLOOD ALKALINE PHOSPHATASE INCREASED 65 0.0026
443 DYSAESTHESIA 8 0.0026
444 RENAL FAILURE CHRONIC 20 0.0026
445 DIASTOLIC DYSFUNCTION 8 0.0026
446 NEPHROGENIC ANAEMIA 12 0.0026
447 HYPOMAGNESAEMIA 36 0.0026
448 ACUTE HEPATIC FAILURE 35 0.0026
449 RENAL FAILURE 339 0.0026
450 PULMONARY TOXICITY 18 0.0025
451 CEREBRAL ISCHAEMIA 13 0.0025
452 CELLULITIS 127 0.0025
453 BONE LESION 9 0.0025
454 ELECTROCARDIOGRAM QT PROLONGED 89 0.0025
455 DIFFUSE LARGE B-CELL LYMPHOMA 19 0.0025
456 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0025
457 NEPHROPATHY 23 0.0025
458 VENTRICULAR ARRHYTHMIA 9 0.0025
459 ORAL DISORDER 18 0.0025
460 NEUROLOGICAL SYMPTOM 14 0.0024
461 ALTERED STATE OF CONSCIOUSNESS 53 0.0024
462 HEPATOMEGALY 24 0.0024
463 ORAL CANDIDIASIS 32 0.0024
464 TORSADE DE POINTES 19 0.0024
465 HAEMATOCRIT DECREASED 48 0.0024
466 ILEUS 30 0.0024
467 RESPIRATORY SYNCYTIAL VIRUS INFECTION 21 0.0024
468 RED CELL DISTRIBUTION WIDTH INCREASED 10 0.0024
469 CARDIAC FAILURE ACUTE 16 0.0024
470 CONFUSIONAL STATE 387 0.0024
471 PROTEIN TOTAL DECREASED 9 0.0024
472 RETINAL HAEMORRHAGE 17 0.0024
473 TROPONIN INCREASED 18 0.0024
474 PNEUMONIA ASPIRATION 59 0.0024
475 THROMBOTIC MICROANGIOPATHY 23 0.0024
476 DRUG LEVEL BELOW THERAPEUTIC 13 0.0024
477 CONJUNCTIVAL HAEMORRHAGE 9 0.0024
478 DEPRESSED LEVEL OF CONSCIOUSNESS 93 0.0023
479 C-REACTIVE PROTEIN INCREASED 85 0.0023
480 BLOOD LACTATE DEHYDROGENASE INCREASED 37 0.0023
481 VARICOSE VEIN 12 0.0023
482 BRAIN INJURY 23 0.0023
483 CYTOMEGALOVIRUS INFECTION 38 0.0023
484 PULMONARY FUNCTION TEST DECREASED 10 0.0023
485 FUNGAL INFECTION 76 0.0023
486 RHABDOMYOLYSIS 95 0.0023
487 GUILLAIN-BARRE SYNDROME 11 0.0023
488 HAEMORRHAGE INTRACRANIAL 34 0.0023
489 MENINGITIS ASEPTIC 10 0.0022
490 TENDERNESS 23 0.0022
491 ATAXIA 26 0.0022
492 BLOOD PHOSPHORUS DECREASED 8 0.0022
493 LUNG INFECTION 34 0.0022
494 ECCHYMOSIS 15 0.0022
495 MOUTH HAEMORRHAGE 16 0.0022
496 SINUS BRADYCARDIA 21 0.0022
497 CYSTIC FIBROSIS 12 0.0022
498 HYPOCALCAEMIA 41 0.0022
499 CARDIOMYOPATHY 32 0.0022
500 COLITIS 82 0.0022
501 SPINAL OSTEOARTHRITIS 19 0.0022
502 HEPATITIS CHOLESTATIC 13 0.0022
503 PERFORMANCE STATUS DECREASED 10 0.0021
504 PERIPHERAL VASCULAR DISORDER 11 0.0021
505 SPLENOMEGALY 25 0.0021
506 NO THERAPEUTIC RESPONSE 26 0.0021
507 PNEUMONIA 689 0.0021
508 LEFT VENTRICULAR HYPERTROPHY 9 0.0021
509 SKIN MASS 14 0.0021
510 SUBDURAL HAEMATOMA 30 0.0021
511 DRUG INTERACTION 330 0.0021
512 PULMONARY OEDEMA 93 0.0021
513 MYELODYSPLASTIC SYNDROME 30 0.0021
514 HEPATIC FUNCTION ABNORMAL 77 0.0021
515 ADRENAL INSUFFICIENCY 25 0.0021
516 CARDIO-RESPIRATORY ARREST 86 0.0021
517 PLATELET COUNT DECREASED 218 0.0020
518 ASCITES 60 0.0020
519 HEPATIC ENCEPHALOPATHY 19 0.0020
520 MITRAL VALVE INCOMPETENCE 23 0.0020
521 TRICUSPID VALVE INCOMPETENCE 16 0.0020
522 ABSCESS 32 0.0020
523 PROTEINURIA 38 0.0020
524 ACUTE PULMONARY OEDEMA 11 0.0020
525 PETIT MAL EPILEPSY 10 0.0020
526 LIVER FUNCTION TEST INCREASED 42 0.0020
527 ATRIAL FIBRILLATION 190 0.0019
528 PULMONARY MASS 29 0.0019
529 HYPONATRAEMIA 109 0.0019
530 APPENDICITIS 18 0.0019
531 PELVIC FRACTURE 15 0.0019
532 METASTASES TO LYMPH NODES 13 0.0019
533 PARTIAL SEIZURES 10 0.0019
534 CARDIAC TAMPONADE 9 0.0019
535 CENTRAL NERVOUS SYSTEM LESION 26 0.0019
536 AORTIC VALVE INCOMPETENCE 8 0.0019
537 HYPERGLYCAEMIA 68 0.0019
538 EJECTION FRACTION DECREASED 29 0.0019
539 OXYGEN SATURATION DECREASED 104 0.0018
540 CHOLECYSTITIS 22 0.0018
541 MYOCARDITIS 21 0.0018
542 JAUNDICE 49 0.0018
543 PETECHIAE 19 0.0018
544 CEREBRAL HAEMORRHAGE 65 0.0018
545 CYTOMEGALOVIRUS INFECTION REACTIVATION 8 0.0018
546 BRADYCARDIA 96 0.0018
547 ANAEMIA 345 0.0018
548 BLOOD CREATINE INCREASED 8 0.0018
549 RESPIRATORY RATE INCREASED 16 0.0018
550 VENTRICULAR FIBRILLATION 20 0.0018
551 HYPOPHAGIA 46 0.0018
552 MENINGITIS 12 0.0018
553 EMPHYSEMA 18 0.0018
554 MYOSITIS 16 0.0018
555 CHOLANGITIS 11 0.0018
556 MELAENA 39 0.0018
557 BODY TEMPERATURE INCREASED 36 0.0018
558 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 18 0.0018
559 GENERALISED TONIC-CLONIC SEIZURE 29 0.0018
560 MULTIPLE INJURIES 11 0.0017
561 PERITONITIS 36 0.0017
562 LARGE INTESTINE PERFORATION 12 0.0017
563 HYPERTRIGLYCERIDAEMIA 10 0.0017
564 END STAGE RENAL DISEASE 31 0.0017
565 NERVOUS SYSTEM DISORDER 53 0.0017
566 LYMPHOPENIA 24 0.0017
567 LIPASE INCREASED 13 0.0017
568 HAEMATURIA 58 0.0017
569 REFUSAL OF TREATMENT BY PATIENT 11 0.0017
570 APNOEA 13 0.0017
571 WHITE BLOOD CELL COUNT DECREASED 181 0.0017
572 VENTRICULAR EXTRASYSTOLES 17 0.0016
573 INTESTINAL ISCHAEMIA 9 0.0016
574 CARDIOMEGALY 20 0.0016
575 GENERAL PHYSICAL CONDITION ABNORMAL 11 0.0016
576 INTRACRANIAL PRESSURE INCREASED 9 0.0016
577 DISORIENTATION 63 0.0016
578 CHOLECYSTITIS ACUTE 9 0.0016
579 GAMMA-GLUTAMYLTRANSFERASE INCREASED 35 0.0016
580 COMA 75 0.0016
581 HERPES VIRUS INFECTION 9 0.0016
582 EOSINOPHIL COUNT INCREASED 13 0.0016
583 ACUTE MYOCARDIAL INFARCTION 46 0.0016
584 ASPIRATION 17 0.0016
585 BENIGN PROSTATIC HYPERPLASIA 8 0.0015
586 VASCULITIS 18 0.0015
587 FACE OEDEMA 26 0.0015
588 BLOOD POTASSIUM INCREASED 25 0.0015
589 HEPATITIS ACUTE 10 0.0015
590 HAEMATEMESIS 39 0.0015
591 WHITE BLOOD CELL COUNT INCREASED 59 0.0015
592 PULMONARY HYPERTENSION 32 0.0015
593 SKIN LESION 42 0.0015
594 DERMATITIS 32 0.0015
595 FACIAL PARALYSIS 13 0.0015
596 PULMONARY CONGESTION 20 0.0015
597 RENAL CYST 12 0.0015
598 HAEMOGLOBIN DECREASED 155 0.0015
599 ARTERIOSCLEROSIS CORONARY ARTERY 10 0.0015
600 MYOPATHY 13 0.0015
601 CONDITION AGGRAVATED 452 0.0015
602 ANAL ABSCESS 8 0.0015
603 DRUG LEVEL DECREASED 15 0.0015
604 HAEMOPTYSIS 41 0.0015
605 POLYURIA 12 0.0015
606 NEPHROTIC SYNDROME 10 0.0015
607 TREATMENT FAILURE 120 0.0014
608 LETHARGY 83 0.0014
609 GASTROINTESTINAL HAEMORRHAGE 120 0.0014
610 UPPER GASTROINTESTINAL HAEMORRHAGE 24 0.0014
611 THERAPY NON-RESPONDER 64 0.0014
612 BLOOD CALCIUM DECREASED 16 0.0014
613 HYPERLIPIDAEMIA 17 0.0014
614 SKIN PLAQUE 12 0.0014
615 ENTERITIS 9 0.0014
616 DRUG TOXICITY 19 0.0014
617 INCOHERENT 9 0.0014
618 PERITONITIS BACTERIAL 14 0.0014
619 PYELONEPHRITIS 12 0.0014
620 PERICARDIAL EFFUSION 32 0.0014
621 OEDEMA 75 0.0014
622 RENAL INJURY 41 0.0014
623 RESPIRATORY ARREST 38 0.0014
624 MOUTH ULCERATION 29 0.0014
625 WOUND INFECTION 15 0.0014
626 HEPATITIS 35 0.0014
627 BLOOD CREATINE PHOSPHOKINASE INCREASED 39 0.0014
628 CIRCULATORY COLLAPSE 23 0.0013
629 HEPATOTOXICITY 30 0.0013
630 DEEP VEIN THROMBOSIS 87 0.0013
631 PANCREATITIS ACUTE 30 0.0013
632 AGITATION 98 0.0013
633 MYELOSUPPRESSION 48 0.0013
634 POSTOPERATIVE WOUND INFECTION 9 0.0013
635 LIVER DISORDER 59 0.0013
636 RED BLOOD CELL COUNT DECREASED 38 0.0013
637 LYMPHADENOPATHY 47 0.0013
638 PRODUCT USE IN UNAPPROVED INDICATION 329 0.0013
639 EMBOLISM 11 0.0013
640 MYOCARDIAL ISCHAEMIA 15 0.0013
641 OFF LABEL USE 1146 0.0013
642 CARDIAC MURMUR 11 0.0013
643 NEUTROPHIL COUNT INCREASED 13 0.0013
644 SPUTUM DISCOLOURED 12 0.0013
645 NEUROLEPTIC MALIGNANT SYNDROME 15 0.0013
646 IMMUNOSUPPRESSION 11 0.0012
647 FISTULA 14 0.0012
648 DISEASE PROGRESSION 147 0.0012
649 TRANSFUSION 13 0.0012
650 METASTASES TO CENTRAL NERVOUS SYSTEM 16 0.0012
651 PRODUCT PRESCRIBING ISSUE 27 0.0012
652 HALLUCINATION 93 0.0012
653 HALLUCINATION, VISUAL 26 0.0012
654 VITAMIN D DEFICIENCY 12 0.0012
655 HAEMARTHROSIS 11 0.0012
656 RENAL DISORDER 57 0.0012
657 THERAPY CHANGE 12 0.0012
658 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
659 ANAPHYLACTIC REACTION 67 0.0012
660 SPINAL COMPRESSION FRACTURE 10 0.0012
661 RESPIRATORY DISORDER 36 0.0012
662 POST PROCEDURAL HAEMORRHAGE 14 0.0012
663 HAEMATOMA 31 0.0012
664 CHILLS 140 0.0012
665 HEPATIC STEATOSIS 22 0.0012
666 DYSPHAGIA 112 0.0012
667 DENTAL CARIES 13 0.0012
668 TOXICITY TO VARIOUS AGENTS 198 0.0012
669 FLANK PAIN 11 0.0012
670 INTERSTITIAL LUNG DISEASE 56 0.0012
671 RESTLESSNESS 42 0.0011
672 DRUG INEFFECTIVE 1505 0.0011
673 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
674 STOMATITIS 69 0.0011
675 DUODENAL ULCER 8 0.0011
676 BRONCHOSPASM 16 0.0011
677 RHINITIS 9 0.0011
678 RESPIRATORY TRACT INFECTION 29 0.0011
679 RASH ERYTHEMATOUS 53 0.0011
680 GASTRITIS 29 0.0011
681 LUNG DISORDER 54 0.0011
682 SEIZURE 127 0.0011
683 MUSCLE TWITCHING 25 0.0011
684 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
685 GRAND MAL CONVULSION 10 0.0011
686 ORAL PAIN 24 0.0011
687 LIVER FUNCTION TEST ABNORMAL 31 0.0011
688 INFECTION 154 0.0011
689 ARTERIOSCLEROSIS 10 0.0011
690 BLOOD SODIUM DECREASED 20 0.0011
691 LEUKAEMIA 10 0.0011
692 GENERAL PHYSICAL HEALTH DETERIORATION 121 0.0010
693 PULMONARY FIBROSIS 20 0.0010
694 ANHEDONIA 27 0.0010
695 CARDIAC FAILURE 82 0.0010
696 BLISTER 57 0.0010
697 EPILEPSY 31 0.0010
698 DISEASE RECURRENCE 48 0.0010
699 IMMUNODEFICIENCY 15 0.0010
700 HIATUS HERNIA 13 0.0010
701 CONVULSION 57 0.0010
702 THERAPY CESSATION 51 0.0010
703 DYSKINESIA 40 0.0010
704 SKIN INFECTION 11 0.0010
705 ABDOMINAL PAIN 227 0.0010
706 METASTASES TO BONE 16 0.0010
707 REBOUND EFFECT 11 0.0010
708 ORAL HERPES 19 0.0010
709 BLOOD PRESSURE DECREASED 64 0.0010
710 RASH PRURITIC 52 0.0010
711 CARDIAC FAILURE CONGESTIVE 77 0.0010
712 INFUSION RELATED REACTION 63 0.0009
713 GASTRIC ULCER 18 0.0009
714 PULMONARY EMBOLISM 90 0.0009
715 POST PROCEDURAL COMPLICATION 18 0.0009
716 MYDRIASIS 12 0.0009
717 BREAST CANCER METASTATIC 10 0.0009
718 MASS 13 0.0009
719 ANGIOEDEMA 41 0.0009
720 RIB FRACTURE 19 0.0009
721 URINARY TRACT INFECTION 156 0.0009
722 PARALYSIS 13 0.0009
723 HYPOGLYCAEMIA 44 0.0009
724 DEHYDRATION 121 0.0009
725 EPISTAXIS 67 0.0009
726 CYANOSIS 14 0.0009
727 SKIN ULCER 23 0.0009
728 ANAL INCONTINENCE 8 0.0009
729 PHARYNGITIS 11 0.0009
730 HEMIPARESIS 15 0.0009
731 OEDEMA PERIPHERAL 106 0.0009
732 URINARY RETENTION 29 0.0009
733 MENTAL IMPAIRMENT 21 0.0009
734 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 45 0.0009
735 COGNITIVE DISORDER 40 0.0009
736 INCONTINENCE 9 0.0009
737 DIABETES MELLITUS INADEQUATE CONTROL 15 0.0008
738 NODULE 11 0.0008
739 CHRONIC KIDNEY DISEASE 64 0.0008
740 THERAPY PARTIAL RESPONDER 13 0.0008
741 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 24 0.0008
742 CEREBRAL INFARCTION 20 0.0008
743 SCAR 14 0.0008
744 RED BLOOD CELL SEDIMENTATION RATE INCREASED 9 0.0008
745 RASH GENERALISED 21 0.0008
746 OBSTRUCTIVE AIRWAYS DISORDER 9 0.0008
747 COVID-19 141 0.0008
748 SEDATION 21 0.0008
749 SECRETION DISCHARGE 10 0.0008
750 HEPATIC CIRRHOSIS 15 0.0008
751 HEPATIC ENZYME INCREASED 54 0.0008
752 IMPAIRED HEALING 26 0.0008
753 OSTEOPENIA 12 0.0008
754 PRESYNCOPE 19 0.0008
755 UPPER RESPIRATORY TRACT INFECTION 36 0.0008
756 PRODUCTIVE COUGH 37 0.0008
757 EYELID OEDEMA 9 0.0008
758 PERICARDITIS 13 0.0008
759 MALIGNANT NEOPLASM PROGRESSION 79 0.0008
760 PLASMA CELL MYELOMA 30 0.0008
761 OSTEONECROSIS OF JAW 19 0.0008
762 RASH 333 0.0008
763 PULMONARY ARTERIAL HYPERTENSION 11 0.0008
764 RASH PAPULAR 17 0.0008
765 PREMATURE DELIVERY 12 0.0008
766 OBESITY 12 0.0008
767 CHROMATURIA 17 0.0008
768 ORTHOSTATIC HYPOTENSION 13 0.0007
769 HYPERTENSION 158 0.0007
770 PHOTOPHOBIA 14 0.0007
771 DYSARTHRIA 28 0.0007
772 PANCREATITIS 39 0.0007
773 ANAPHYLACTIC SHOCK 19 0.0007
774 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
775 DYSURIA 27 0.0007
776 MUSCLE SPASTICITY 9 0.0007
777 CHOLELITHIASIS 24 0.0007
778 CORONARY ARTERY DISEASE 22 0.0007
779 NEOPLASM PROGRESSION 25 0.0007
780 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
781 HAEMORRHOIDS 14 0.0007
782 BONE DISORDER 13 0.0007
783 WHEEZING 42 0.0007
784 PAIN IN JAW 20 0.0007
785 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
786 PALLOR 19 0.0007
787 DYSPNOEA EXERTIONAL 26 0.0007
788 RASH MACULAR 24 0.0007
789 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
790 INTENTIONAL PRODUCT USE ISSUE 60 0.0007
791 COUGH 192 0.0007
792 IMMUNE SYSTEM DISORDER 9 0.0007
793 INFLAMMATION 35 0.0007
794 DIARRHOEA 433 0.0007
795 GOUT 12 0.0007
796 PHOTOSENSITIVITY REACTION 11 0.0007
797 SKIN FISSURES 13 0.0007
798 PREMATURE BABY 20 0.0007
799 TOOTHACHE 12 0.0007
800 MATERNAL EXPOSURE DURING PREGNANCY 59 0.0007
801 ABDOMINAL DISTENSION 69 0.0007
802 ECONOMIC PROBLEM 10 0.0007
803 ERYTHEMA 135 0.0007
804 MUSCULOSKELETAL CHEST PAIN 10 0.0006
805 EXTRAPYRAMIDAL DISORDER 16 0.0006
806 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 15 0.0006
807 VOMITING 302 0.0006
808 HAEMORRHAGE 67 0.0006
809 INJURY 45 0.0006
810 DYSPNOEA 362 0.0006
811 DECREASED APPETITE 148 0.0006
812 FRACTURE 12 0.0006
813 MUSCULAR WEAKNESS 72 0.0006
814 LOCAL SWELLING 11 0.0006
815 ASTHENIA 237 0.0006
816 ACCIDENTAL OVERDOSE 23 0.0006
817 SKIN EXFOLIATION 53 0.0006
818 HYPOTHYROIDISM 20 0.0006
819 DEAFNESS 16 0.0006
820 SPEECH DISORDER 32 0.0006
821 SYNCOPE 61 0.0006
822 BRONCHITIS 45 0.0006
823 TREATMENT NONCOMPLIANCE 33 0.0006
824 THROMBOSIS 48 0.0006
825 ARRHYTHMIA 28 0.0006
826 SOMNOLENCE 119 0.0006
827 TREMOR 98 0.0006
828 INSURANCE ISSUE 9 0.0006
829 INTESTINAL OBSTRUCTION 22 0.0006
830 DIABETIC KETOACIDOSIS 14 0.0006
831 DIVERTICULITIS 16 0.0006
832 METASTASES TO LIVER 10 0.0006
833 CONSTIPATION 123 0.0006
834 EXPOSURE DURING PREGNANCY 35 0.0006
835 CONJUNCTIVITIS 10 0.0005
836 URTICARIA 90 0.0005
837 WOUND 15 0.0005
838 CHEST PAIN 98 0.0005
839 MENTAL DISORDER 23 0.0005
840 BLOOD COUNT ABNORMAL 8 0.0005
841 PARANOIA 9 0.0005
842 FEAR 14 0.0005
843 DISTURBANCE IN ATTENTION 28 0.0005
844 DYSTONIA 10 0.0005
845 ISCHAEMIC STROKE 9 0.0005
846 NEPHROLITHIASIS 23 0.0005
847 BLOOD POTASSIUM DECREASED 15 0.0005
848 NAUSEA 382 0.0005
849 OVERDOSE 104 0.0005
850 SWELLING 45 0.0005
851 BACK PAIN 111 0.0005
852 ECZEMA 25 0.0005
853 NEUROPATHY PERIPHERAL 45 0.0005
854 URINARY INCONTINENCE 14 0.0005
855 SLEEP APNOEA SYNDROME 9 0.0005
856 CYSTITIS 15 0.0005
857 HERPES ZOSTER 27 0.0005
858 RETCHING 10 0.0005
859 SINUSITIS 48 0.0005
860 RECTAL HAEMORRHAGE 20 0.0005
861 PRESCRIBED OVERDOSE 9 0.0005
862 HAEMATOCHEZIA 25 0.0005
863 INFLUENZA 50 0.0004
864 HYPERSENSITIVITY 83 0.0004
865 SWELLING FACE 29 0.0004
866 HEART RATE INCREASED 44 0.0004
867 TASTE DISORDER 9 0.0004
868 OSTEOPOROSIS 18 0.0004
869 GASTROINTESTINAL DISORDER 39 0.0004
870 LIP SWELLING 14 0.0004
871 DIABETES MELLITUS 32 0.0004
872 NO ADVERSE EVENT 76 0.0004
873 BLOOD GLUCOSE DECREASED 20 0.0004
874 LOCALISED INFECTION 10 0.0004
875 OROPHARYNGEAL PAIN 38 0.0004
876 BONE PAIN 24 0.0004
877 NIGHT SWEATS 13 0.0004
878 BLOOD PRESSURE ABNORMAL 8 0.0004
879 OSTEOARTHRITIS 17 0.0004
880 HEART RATE DECREASED 14 0.0004
881 LOSS OF CONSCIOUSNESS 51 0.0004
882 FALL 132 0.0004
883 PROCEDURAL PAIN 11 0.0004
884 SYSTEMIC LUPUS ERYTHEMATOSUS 14 0.0004
885 ANXIETY 111 0.0004
886 SKIN DISORDER 13 0.0004
887 HYPERHIDROSIS 50 0.0004
888 GASTROOESOPHAGEAL REFLUX DISEASE 31 0.0004
889 IRRITABILITY 23 0.0004
890 AGGRESSION 19 0.0004
891 THERAPEUTIC RESPONSE DECREASED 23 0.0004
892 THERAPY INTERRUPTED 27 0.0004
893 CEREBROVASCULAR ACCIDENT 64 0.0004
894 PRODUCT USE ISSUE 71 0.0004
895 MYALGIA 64 0.0004
896 DYSPHONIA 22 0.0004
897 NECK PAIN 21 0.0004
898 FREQUENT BOWEL MOVEMENTS 10 0.0004
899 FOETAL EXPOSURE DURING PREGNANCY 30 0.0004
900 DEATH 316 0.0004
901 OSTEONECROSIS 12 0.0004
902 MUSCULOSKELETAL PAIN 19 0.0004
903 PRURITUS 137 0.0004
904 ABDOMINAL PAIN LOWER 9 0.0004
905 AMNESIA 23 0.0004
906 CONTUSION 34 0.0004
907 DRUG WITHDRAWAL SYNDROME 30 0.0003
908 MEDICATION ERROR 19 0.0003
909 WEIGHT DECREASED 94 0.0003
910 PAIN IN EXTREMITY 99 0.0003
911 CHEST DISCOMFORT 34 0.0003
912 VIRAL INFECTION 11 0.0003
913 GAIT INABILITY 11 0.0003
914 ABNORMAL BEHAVIOUR 13 0.0003
915 SKIN DISCOLOURATION 15 0.0003
916 PALPITATIONS 37 0.0003
917 HYPERSOMNIA 9 0.0003
918 DRUG INTOLERANCE 30 0.0003
919 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22 0.0003
920 NASAL CONGESTION 18 0.0003
921 PSYCHOTIC DISORDER 9 0.0003
922 UNEVALUABLE EVENT 23 0.0003
923 TYPE 2 DIABETES MELLITUS 10 0.0003
924 FLUID RETENTION 15 0.0003
925 RHINORRHOEA 19 0.0003
926 BLOOD GLUCOSE INCREASED 55 0.0003
927 FATIGUE 225 0.0003
928 HEADACHE 181 0.0003
929 DEMENTIA 8 0.0003
930 EMOTIONAL DISTRESS 34 0.0003
931 ANGINA PECTORIS 8 0.0003
932 PAIN 171 0.0003
933 CARDIAC DISORDER 25 0.0003
934 HOSPITALISATION 41 0.0003
935 WITHDRAWAL SYNDROME 11 0.0003
936 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
937 ABDOMINAL PAIN UPPER 51 0.0002
938 DISCOMFORT 15 0.0002
939 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
940 VISUAL IMPAIRMENT 30 0.0002
941 DEPRESSION 55 0.0002
942 WEIGHT INCREASED 52 0.0002
943 BALANCE DISORDER 20 0.0002
944 DIZZINESS 114 0.0002
945 VISION BLURRED 30 0.0002
946 BLOOD PRESSURE INCREASED 33 0.0002
947 HYPOAESTHESIA 32 0.0002
948 PARAESTHESIA 33 0.0002
949 DRY MOUTH 17 0.0002
950 MYOCARDIAL INFARCTION 36 0.0002
951 SURGERY 12 0.0002
952 ASTHMA 23 0.0002
953 DYSGEUSIA 15 0.0002
954 MALAISE 88 0.0002
955 BURNING SENSATION 14 0.0002
956 ARTHROPATHY 11 0.0002
957 ILL-DEFINED DISORDER 12 0.0002
958 VERTIGO 12 0.0002
959 ABDOMINAL DISCOMFORT 33 0.0002
960 MOBILITY DECREASED 14 0.0002
961 PERIPHERAL SWELLING 30 0.0002
962 OCULAR HYPERAEMIA 9 0.0002
963 MUSCLE SPASMS 34 0.0002
964 ARTHRALGIA 77 0.0002
965 INFLUENZA LIKE ILLNESS 15 0.0002
966 ADVERSE DRUG REACTION 16 0.0002
967 ARTHRITIS 14 0.0002
968 SUICIDAL IDEATION 16 0.0002
969 MEMORY IMPAIRMENT 24 0.0002
970 GAIT DISTURBANCE 33 0.0002
971 INSOMNIA 44 0.0002
972 FEELING HOT 10 0.0002
973 DRY EYE 8 0.0002
974 PRODUCT DOSE OMISSION 10 0.0002
975 INTENTIONAL PRODUCT MISUSE 13 0.0001
976 ILLNESS 15 0.0001
977 INJECTION SITE REACTION 10 0.0001
978 DYSPEPSIA 14 0.0001
979 FLUSHING 14 0.0001
980 MUSCULOSKELETAL STIFFNESS 12 0.0001
981 NEOPLASM MALIGNANT 9 0.0001
982 SLEEP DISORDER 9 0.0001
983 INCORRECT DOSE ADMINISTERED 29 0.0001
984 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
985 JOINT SWELLING 14 0.0001
986 ALOPECIA 22 0.0001
987 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
988 ADVERSE EVENT 10 0.0001
989 DRY SKIN 14 0.0001
990 NASOPHARYNGITIS 17 0.0001
991 PRODUCT DOSE OMISSION ISSUE 25 0.0001
992 PSORIASIS 9 0.0001
993 FEELING ABNORMAL 15 0.0001
994 INJECTION SITE PAIN 9 0.0000